Multiple sclerosis drugs on AARP Medicare Rx Preferred from UHC (S5921-396)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Indiana + 1 more
- Premium
- $127.10/month
- Deductible
- $130.00, doesn't apply to tier 1 and 2
3 of 8 Multiple sclerosis drugs are covered on this plan. None require prior authorization.
5 aren't on the formulary, including Kesimpta and Vumerity.
- from $17.59Tier 4
- from $25.51Tier 4
- $92.09Tier 4
Not on the formulary
Kesimpta, Vumerity, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $130.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.